We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
-12.36%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$12.7B
AUM Growth
-$3.96B
Cap. Flow
-$1.66B
Cap. Flow %
-13.11%
Top 10 Hldgs %
14.02%
Holding
2,200
New
84
Increased
771
Reduced
1,166
Closed
158
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SWKS icon
251
Skyworks Solutions
SWKS
$10.1B
$12M 0.09%
129,298
-45
-0% -$4.86K
CLX icon
252
Clorox
CLX
$12.8B
$11.9M 0.09%
84,452
-1,995
-2% -$285K
DSU icon
253
BlackRock Debt Strategies Fund
DSU
$595M
$11.8M 0.09%
1,292,762
+207,544
+19% +$2.02M
ORCL icon
254
Oracle
ORCL
$413B
$11.7M 0.09%
168,099
-68,031
-29% -$4.98M
NZF icon
255
Nuveen Municipal Credit Income Fund
NZF
$2.43B
$11.7M 0.09%
934,604
+261,336
+39% +$3.4M
BDX icon
256
Becton Dickinson
BDX
$48.8B
$11.7M 0.09%
47,550
-1,441
-3% -$366K
JCI icon
257
Johnson Controls International
JCI
$93.6B
$11.7M 0.09%
244,615
-11,419
-4% -$636K
CW icon
258
Curtiss-Wright
CW
$26.4B
$11.7M 0.09%
88,330
+28,478
+48% +$4.04M
LKQ icon
259
LKQ Corp
LKQ
$6.19B
$11.6M 0.09%
236,971
-33,458
-12% -$1.65M
HSIC icon
260
Henry Schein
HSIC
$9.83B
$11.6M 0.09%
151,364
-19,241
-11% -$1.61M
SHY icon
261
iShares 1-3 Year Treasury Bond ETF
SHY
$25.1B
$11.6M 0.09%
140,047
-16,343
-10% -$1.36M
EVH icon
262
Evolent Health
EVH
$404M
$11.6M 0.09%
377,233
-103,143
-21% -$3.01M
IGA
263
Voya Global Advantage and Premium Opportunity Fund
IGA
$156M
$11.5M 0.09%
1,266,098
-89,624
-7% -$836K
LDOS icon
264
Leidos
LDOS
$17B
$11.5M 0.09%
114,292
-15,047
-12% -$1.56M
ADC icon
265
Agree Realty
ADC
$9.5B
$11.5M 0.09%
159,517
-27,230
-15% -$1.89M
KNX icon
266
Knight Transportation
KNX
$11.3B
$11.3M 0.09%
245,109
-989
-0.4% -$46.8K
MPT
267
Medical Properties Trust
MPT
$2.75B
$11.3M 0.09%
741,029
-399,193
-35% -$7.18M
LNT icon
268
Alliant Energy
LNT
$18B
$11.2M 0.09%
191,340
-29,320
-13% -$1.77M
FCX icon
269
Freeport-McMoran
FCX
$95.5B
$11.1M 0.09%
380,862
+64,264
+20% +$2.57M
CUZ icon
270
Cousins Properties
CUZ
$4.91B
$11.1M 0.09%
378,229
+297,816
+370% +$10.3M
GPK icon
271
Graphic Packaging
GPK
$3.51B
$11.1M 0.09%
539,254
+25,037
+5% +$529K
T icon
272
AT&T
T
$162B
$11M 0.09%
522,992
-331,659
-39% -$6.61M
MVF
273
DELISTED
BlackRock MuniVest Fund
MVF
$11M 0.09%
1,471,075
-16,691
-1% -$126K
PPL
274
PPL Corp
PPL
$26B
$10.9M 0.09%
402,461
-141,045
-26% -$4.05M
BOE icon
275
BlackRock Enhanced Global Dividend Trust
BOE
$683M
$10.9M 0.09%
1,113,985
+87,442
+9% +$919K

Similar funds

Guggenheim Capital's Q2 2022 Portfolio in Review

As of Q2 2022, Guggenheim Capital held 2,200 positions worth $12.7B, down 24% from $16.6B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Guggenheim Capital withdrew a net $1.66B in Q2 2022, closing 158 positions and reducing 1,166 holdings. Its most notable exit was BLACKROCK MUNIYIELD CALIFORNIA QUALITY FUND, INC, an estimated $13.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Guggenheim Capital opened a new position in ESAB worth $3.14M.

  • Guggenheim Capital's largest Q2 2022 buy was ESAB: 71,750 shares worth $3.14M.
  • Guggenheim Capital added most to Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in Q2 2022, an estimated $25.1M increase.
  • Guggenheim Capital's biggest Q2 2022 reduction was Apple, cutting an estimated $68.5M.
  • Guggenheim Capital fully exited BLACKROCK MUNIYIELD CALIFORNIA QUALITY FUND, INC in Q2 2022, selling an estimated $13.1M.
  • Guggenheim Capital's ten largest holdings make up 14% of its $12.7B portfolio in Q2 2022.
  • Guggenheim Capital opened 84 new positions and closed 158 in Q2 2022.
  • Guggenheim Capital's portfolio value fell 24% quarter-over-quarter to $12.7B.

Based on Guggenheim Capital's 13F filing for Q2 2022, filed 15 Aug 2022.